A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T Cells in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Age: 16-75 years
Phase: Phase 2
Locations:
- London – University College London Hospital
- Manchester – The Christie NHS Foundation Trust
This study aims to find out how safe the drug ADP-A2M4 is and how effective it is at attacking synovial sarcoma or Myxoid/Round Cell Liposarcoma cancer cells.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
